| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |